Tumor vaccines and beyond
- PMID: 21067312
- PMCID: PMC8751546
- DOI: 10.3109/14653249.2010.530649
Tumor vaccines and beyond
Abstract
For the last two decades the immunotherapy of patients with solid and hematopoietic tumors has met with variable success. We have reviewed the field of tumor vaccines to examine what has worked and what has not, why this has been the case, how the anti-tumor responses were examined, and how we can make tumor immunity successful for the majority of individuals rather than for the exceptional patients who currently show successful immune responses against their tumors.
Conflict of interest statement
References
-
- Fialkow P, Singer J, Adamson J, Vaidya K, Dow L, Ochs J, et al. Acute nonlymphocytic leukemia: heterogeneity of stem cell origin. Blood 1981;57:1068–73. - PubMed
-
- Fialkow PJ, Singer JW, Raskind WH, Adamson JW, Jacobson RJ, Bernstein ID, et al. Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia. N Engl J Med 1987;317:468–73. - PubMed
-
- Fearon ER, Hamilton SR, Vogelstein B. Clonal analysis of human colorectal tumors. Science 1987;238:193–7. - PubMed
-
- Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525–32. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
